Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - AGENUS INC | Financial_Report.xls |
| EX-32.1 - CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 906 - AGENUS INC | agen-123114ex321.htm |
| EX-23.1 - EXHIBIT 23.1 - AGENUS INC | agen-123114xex23.htm |
| EX-10.8 - EXHIBIT 10.8 - AGENUS INC | agen-123114xex108.htm |
| EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AGENUS INC | agen-123114xex312.htm |
| EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AGENUS INC | agen-123114xex311.htm |
| EX-4.21 - EXHIBIT 4.21 - AGENUS INC | agen-123114xex421.htm |
| EX-10.21 - EXHIBIT 10.21 - AGENUS INC | agen-123114xex1021.htm |
| EX-10.22 - EXHIBIT 10.22 - AGENUS INC | agen-123113xex1022xincytec.htm |
| 10-K - 10-K - AGENUS INC | agen-12312014x10k.htm |
EXHIBIT 21.1
SUBSIDIARIES OF AGENUS INC.
Antigenics Inc., a wholly owned subsidiary of Agenus Inc., is incorporated in Massachusetts.
Aronex Pharmaceuticals, Inc., a wholly owned subsidiary of Agenus Inc., is incorporated in Delaware.
Antigenics Therapeutics Limited, a wholly owned subsidiary of Agenus Inc., is organized under the laws of Ireland.
4-AntibodyAG, a joint stock company under the laws of Switzerland (as of February 12, 2014).